The Production of Therapeutic Proteins in Plants: Apo AI and Insulin
The Production of Therapeutic Proteins in Plants: Apo AI and Insulin The Production of Therapeutic Proteins in Plants: Apo AI and Insulin
from mediaserver.aaps.org
More from this publisher
13.07.2015
Views
SemBioSys’ NicheSemBioSys focuses on finding existing protein based drugsof therapeutic interest or other products such as specialty oilsfor which there is an unmet need.SemBioSys addresses demand/protein availability issueswith a lower cost production system. SemBioSys is aplatform technology company.
SemBioSys’ TechnologyProof-of-ConceptArabidopsis thalianaCommercial Production SpeciesSafflower (Carthamus tinctorius)
- Page 1 and 2: The Production of Therapeutic Prote
- Page 3: SemBioSys OverviewLocation: Calgary
- Page 7 and 8: Field Grown GMO SafflowerPlanting s
- Page 9 and 10: Purification of OilbodiesThe Proces
- Page 11 and 12: Plant Impurity AssaysPhytate (IP 6
- Page 13 and 14: Product Impurity Assays - Fusion Pa
- Page 15 and 16: Viral Load/Viral ClearanceRegulator
- Page 17 and 18: InsulinPositioned to Meet the Growi
- Page 19 and 20: Economics of Plant-Produced Insulin
- Page 21 and 22: Insulin - Equivalence DataV8 Protea
- Page 23 and 24: Insulin - Equivalence DataIGF-1 Rec
- Page 25 and 26: Insulin Characterization: Clinical
- Page 27 and 28: Apo AI Milano (SBS-2000)• FTO - S
- Page 29 and 30: Functional Characterization of Puri
- Page 31 and 32: Cholesterol Mobilization in vivoSBS
- Page 33: Non-Pharma ProductsProducts and Com
SemBioSys’ TechnologyPro<strong>of</strong>-<strong>of</strong>-ConceptArabidopsis thalianaCommercial <strong>Production</strong> SpeciesSafflower (Carthamus t<strong>in</strong>ctorius)
Change language